Found: 16
Select item for more details and to access through your institution.
Loss of IL-15 receptor α alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles.
- Published in:
- 2011
- By:
- Publication type:
- journal article
IL-18 is not therapeutic for neovascular age-related macular degeneration.
- Published in:
- Nature Medicine, 2014, v. 20, n. 12, p. 1372, doi. 10.1038/nm.3671
- By:
- Publication type:
- Article
Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C.
- Published in:
- Muscle & Nerve, 2008, v. 37, n. 3, p. 308, doi. 10.1002/mus.20920
- By:
- Publication type:
- Article
Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.
- Published in:
- Journal of Molecular Medicine, 2004, v. 82, n. 2, p. 102, doi. 10.1007/s00109-003-0484-1
- By:
- Publication type:
- Article
Author Correction: High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-58737-6
- By:
- Publication type:
- Article
Targeting latent TGFβ release in muscular dystrophy.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 259, p. 1, doi. 10.1126/scitranslmed.3010018
- By:
- Publication type:
- Article
Differential Expression of Utrophin-A and -B Promoters in the Central Nervous System (CNS) of Normal and Dystrophic mdx Mice.
- Published in:
- Brain Pathology, 2010, v. 20, n. 2, p. 323, doi. 10.1111/j.1750-3639.2009.00275.x
- By:
- Publication type:
- Article
Myostatin propeptide-mediated amelioration of dystrophic pathophysiology.
- Published in:
- FASEB Journal, 2005, v. 19, n. 6, p. 543, doi. 10.1096/fj.04-2796com
- By:
- Publication type:
- Article
Functional improvement of dystrophic muscle by myostatin blockade.
- Published in:
- Nature, 2002, v. 420, n. 6914, p. 418, doi. 10.1038/nature01154
- By:
- Publication type:
- Article
Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 25, p. 6722, doi. 10.1093/hmg/ddu390
- By:
- Publication type:
- Article
Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 25, p. 1, doi. 10.1093/hmg/ddu390
- By:
- Publication type:
- Article
Short-interfering RNAs Induce Retinal Degeneration via TLR3 and IRF3.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 1, p. 101, doi. 10.1038/mt.2011.212
- By:
- Publication type:
- Article
Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 6, p. 1961, doi. 10.1007/s40120-023-00532-2
- By:
- Publication type:
- Article
Anti-Oxidative Response of Carbonic Anhydrase III in Skeletal Muscle.
- Published in:
- IUBMB Life, 2004, v. 56, n. 6, p. 343, doi. 10.1080/1521-6540400000850
- By:
- Publication type:
- Article
Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
- Published in:
- PLoS Genetics, 2016, v. 12, n. 5, p. 1, doi. 10.1371/journal.pgen.1006019
- By:
- Publication type:
- Article